Survival analyses showed that high SMC4 mRNA expression was negatively correlated with prognosis in both patients with lower-grade glioma and patients with GBM (Supplementary Figure S1) from TCGA data set, suggesting that the expression of SMC4 mRNA is an indicator of survival in glioma. Here, SMC4 is linked to glioblastoma.